246 related articles for article (PubMed ID: 30522865)
1. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance.
Sun Y; Xu H; Chen X; Li X; Luo B
Biochem Biophys Res Commun; 2019 Jan; 508(2):626-632. PubMed ID: 30522865
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage.
Tan J; Song M; Zhou M; Hu Y
Biochem Biophys Res Commun; 2017 Jan; 483(1):17-23. PubMed ID: 28069382
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone at clinically relevant concentration overcomes chemoresistance in ovarian cancer via inhibiting mitochondrial respiration.
Guo Y; Hu B; Fu B; Zhu H
Pathol Res Pract; 2021 Aug; 224():153529. PubMed ID: 34174549
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the miR-325-3p/DPAGT1 axis supports HBV-positive HCC chemoresistance.
Li R; Xu T; Wang H; Wu N; Liu F; Jia X; Mi J; Lv J; Gao H
Biochem Biophys Res Commun; 2019 Nov; 519(2):358-365. PubMed ID: 31519321
[TBL] [Abstract][Full Text] [Related]
6. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
Chen D; Sun X; Zhang X; Cao J
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
[TBL] [Abstract][Full Text] [Related]
7. TFAM depletion overcomes hepatocellular carcinoma resistance to doxorubicin and sorafenib through AMPK activation and mitochondrial dysfunction.
Zhu Y; Xu J; Hu W; Wang F; Zhou Y; Xu W; Gong W; Shao L
Gene; 2020 Aug; 753():144807. PubMed ID: 32461017
[TBL] [Abstract][Full Text] [Related]
8. 9-bis[2-(pyrrolidin-1-yl)ethoxy]-6-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-11H-indeno[1, 2-c]quinolin-11-one (BPIQ), A Quinoline Derivative Inhibits Human Hepatocellular Carcinoma Cells by Inducing ER Stress and Apoptosis.
Chang WT; Fong Y; Chuang SC; Chou CK; Chou HL; Yang CF; Tseng CH; Chen YL; Chiu CC
Anticancer Agents Med Chem; 2017; 17(5):692-700. PubMed ID: 27491935
[TBL] [Abstract][Full Text] [Related]
9. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
You ML; Chen YJ; Chong QY; Wu MM; Pandey V; Chen RM; Liu L; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Jun; 8(24):39323-39344. PubMed ID: 28445151
[TBL] [Abstract][Full Text] [Related]
10. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and metabolic reprogramming.
Chen H; Wu D; Bao L; Yin T; Lei D; Yu J; Tong X
Biomed Pharmacother; 2019 Mar; 111():1353-1358. PubMed ID: 30841449
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
12. Chamaejasmenin E from Stellera chamaejasme induces apoptosis of hepatocellular carcinoma cells by targeting c-Met in vitro and in vivo.
Yu XQ; Yan QL; Shen S; Cheng ZY; Huang XX; Yao GD; Song SJ
Bioorg Chem; 2022 Feb; 119():105509. PubMed ID: 34844768
[TBL] [Abstract][Full Text] [Related]
13. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation.
Li P; Liu Y; He Q
Drug Des Devel Ther; 2020; 14():1609-1620. PubMed ID: 32425506
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and functional role of transmembrane protein 47 (TMEM47) in chemoresistance of hepatocellular carcinoma.
Ng KT; Yeung OW; Liu J; Li CX; Liu H; Liu XB; Qi X; Ma YY; Lam YF; Lau MY; Qiu WQ; Shiu HC; Lai MK; Lo CM; Man K
Int J Oncol; 2020 Oct; 57(4):956-966. PubMed ID: 32945373
[TBL] [Abstract][Full Text] [Related]
16. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma.
Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y
Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730
[TBL] [Abstract][Full Text] [Related]
17. Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin-induced eIF4E activation.
Tan J; Ye J; Song M; Zhou M; Hu Y
J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 29112301
[TBL] [Abstract][Full Text] [Related]
18. Antibody against granulin-epithelin precursor sensitizes hepatocellular carcinoma to chemotherapeutic agents.
Wong NC; Cheung PF; Yip CW; Chan KF; Ng IO; Fan ST; Cheung ST
Mol Cancer Ther; 2014 Dec; 13(12):3001-12. PubMed ID: 25253787
[TBL] [Abstract][Full Text] [Related]
19. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
20. Proscillaridin A inhibits hepatocellular carcinoma progression through inducing mitochondrial damage and autophagy.
Luo M; Liu Y; Liu N; Shao W; Ming L; Liu J; Xie Y
Acta Biochim Biophys Sin (Shanghai); 2021 Jan; 53(1):19-28. PubMed ID: 33201987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]